Synairgen plc (AIM:SNG)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.864
-0.186 (-17.71%)
Mar 25, 2025, 12:44 PM GMT+1
-77.38%
Market Cap 11.03M
Revenue (ttm) n/a
Net Income (ttm) -6.92M
Shares Out 1.10B
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 123,381
Average Volume 1,435,458
Open 0.860
Previous Close 1.050
Day's Range 0.802 - 1.024
52-Week Range 0.602 - 10.000
Beta -2.00
RSI 31.98
Earnings Date May 9, 2025

About Synairgen

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 36
Stock Exchange London Stock Exchange AIM
Ticker Symbol SNG
Full Company Profile

Financial Performance

Financial Statements

News

AIM Market Roundup: CMO, Tungsten West, Rockfire

CMO, Tungsten West, Rockfire Resources, Thruvision, Synairgen are today's biggest risers and fallers on London's AIM market

13 days ago - The Armchair Trader

AIM Market Roundup: GCM Resources, Deltic Energy, Solid State

GCM Resources, Deltic Energy, Solid State, Synairgen, Thruvision are today's biggest risers and fallers on London's AIM market

14 days ago - The Armchair Trader

AIM Market Roundup: Mkango, N4 Pharma, Minoan

Mkango Resources, N4 Pharma, Minoan, RBG Holdings, Synairgen are today's biggest risers and fallers on London's AIM market

2 months ago - The Armchair Trader

Small Cap Stocks: Borders & Southern, GENIP, Smarttech 247

Borders & Southern, Genip, Smarttech247, Synairgen, Quadrise are today's biggest Small Cap stock movers

2 months ago - The Armchair Trader